Raymond James & Associates’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
2017
Q3
$2.34M Buy
2017
Q2
$1.3M Sell
2017
Q1
$1.4M Buy
2016
Q4
$551K Buy
2016
Q3
$352K Buy
2016
Q2
Sell
2016
Q1
$297K Buy